Validation and evaluation of clinical prediction systems for first and repeated transarterial chemoembolization in unresectable hepatocellular carcinoma: A Chinese multicenter retrospective study

BACKGROUND: The treatment outcome of transarterial chemoembolization (TACE) in unresectable hepatocellular carcinoma (HCC) varies greatly due to the clinical heterogeneity of the patients. Therefore, several prognostic systems have been proposed for risk stratification and candidate identification f...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhe-Xuan, Wang, En-Xin, Bai, Wei, Xia, Dong-Dong, Mu, Wei, Li, Jing, Yang, Qiao-Yi, Huang, Ming, Xu, Guo-Hui, Sun, Jun-Hui, Li, Hai-Liang, Zhao, Hui, Wu, Jian-Bing, Yang, Shu-Fa, Li, Jia-Ping, Li, Zi-Xiang, Zhang, Chun-Qing, Zhu, Xiao-Li, Zheng, Yan-Bo, Wang, Qiu-He, Yuan, Jie, Li, Xiao-Mei, Niu, Jing, Yin, Zhan-Xin, Xia, Jie-Lai, Fan, Dai-Ming, Han, Guo-Hong, on behalf of China HCC-TACE Study Group
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029354/
https://www.ncbi.nlm.nih.gov/pubmed/32103874
http://dx.doi.org/10.3748/wjg.v26.i6.657

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029354/
https://www.ncbi.nlm.nih.gov/pubmed/32103874
http://dx.doi.org/10.3748/wjg.v26.i6.657

Ejemplares similares